Repeat-dose Administration
Repeat-Dose Administration is a methodological framework in pharmacological research that involves the systematic and controlled delivery of multiple doses of a therapeutic agent over a defined period to evaluate cumulative effects, pharmacokinetic stability, and long-term safety profiles in comparison to single-dose regimens.
274
Publications
14.3K
Citations
2.1K
Authors
661
Institutions
Publications per year
2017–2026
60
Variants
Multiple-dose Administration
Parents
274
Stephen A. Boorjian, Mehrdad Alemozaffar, Badrinath R. Konety et al. · The Lancet Oncology · 2020 · 442 citations · Full text
1–5 of 274
2.1K
4
h-index
4
h-index
4
h-index
4
h-index
4
h-index
1–5 of 2.1K
661

Research Triangle Park Foundation
Durham, United States
14 h-index
59 publications
2K citations
GlaxoSmithKline (United States)
Philadelphia, United States
12 h-index
46 publications
2K citations

GlaxoSmithKline (United Kingdom)
London, United Kingdom
10 h-index
63 publications
3.7K citations

University of Toronto
Toronto, Canada
7 h-index
34 publications
1.4K citations
Pfizer (United States)
New York, United States
6 h-index
34 publications
1.1K citations
Bristol-Myers Squibb (United States)
New York, United States
5 h-index
12 publications
383 citations
University Health Network
Toronto, Canada
4 h-index
42 publications
1.7K citations
Janssen (United States)
Hopewell, United States
4 h-index
9 publications
627 citations
1–8 of 661
Repository · 14 publications · 1.4K citations
11
h-index
10 publications · 462 citations
10
h-index
9 publications · 301 citations
9
h-index
AAC · 9 publications · 427 citations
9
h-index
8 publications · 256 citations
8
h-index
1–5